Medpace Holdings MEDP
NASDAQ MEDP
$611.39 -7.66 (-1.24%)
As of: Aug 27, 2026 · 3:59 PM EDT

Medpace Holdings (MEDP) Total Non-Current Liabilities (2015 - 2026)

Medpace Holdings' (MEDP) quarterly Total Non-Current Liabilities came in at $1.6 billion in Q2 2026, up 16.06% YoY from $1.3 billion in Q2 2025, and up 6.29% on a QoQ basis from $1.5 billion in Q1 2026.

Medpace Holdings (MEDP) Total Non-Current Liabilities (2015 - 2026) Analysis & Trends

Medpace Holdings (MEDP) has 12 years of Total Non-Current Liabilities data on file, last reported at $1.6 billion in Q2 2026.

  • Quarterly Total Non-Current Liabilities rose 16.06% year-over-year to $1.6 billion in Q2 2026, while the trailing twelve-month figure through Jun 2026 was $1.6 billion (up 16.06% YoY) and the FY2025 annual result came in at $1.5 billion, up 18.35% from the prior year.
  • Total Non-Current Liabilities rose to $1.6 billion in Q2 2026, from $1.5 billion in the prior quarter.
  • In the past five years, Total Non-Current Liabilities ranged from a high of $1.6 billion in Q2 2026 to a low of $722.1 million in Q1 2022.
  • A 5-year average of $1.2 billion and a median of $1.1 billion in 2024 frame the typical range for Total Non-Current Liabilities.
  • Annual changes were most pronounced in 2022 — Total Non-Current Liabilities surged 68.68% — and 2023, when it fell 2.17%.
  • Tracing MEDP's Total Non-Current Liabilities over 5 years: stood at $943.4 million in 2022, then increased by 13.38% to $1.1 billion in 2023, then rose by 15.23% to $1.2 billion in 2024, then climbed by 18.35% to $1.5 billion in 2025, then climbed by 7.2% to $1.6 billion in 2026.
  • The last three Total Non-Current Liabilities figures came in at $1.6 billion (Q2 2026), $1.5 billion (Q1 2026), and $1.5 billion (Q4 2025), per Business Quant data.

Peer Comparison

# Company Market Cap Enterprise Value Gross Profit (Qtr) Total Non-Current Liabilities (Qtr)
1 Thermo Fisher Scientific 234.15 Bn 230.09 Bn 8.34 Bn 108.64 Bn
2 Danaher 152.10 Bn 147.75 Bn 3.61 Bn 85.84 Bn
3 Natera 48.48 Bn 47.38 Bn 486.15 Mn 715.49 Mn
4 Agilent Technologies 44.35 Bn 42.55 Bn 990.00 Mn 5.45 Bn
5 Iqvia Holdings 43.68 Bn 41.60 Bn 1.44 Bn 22.94 Bn
6 Idexx Laboratories 43.02 Bn 42.83 Bn 779.09 Mn 542.10 Mn
7 Illumina 34.39 Bn 33.22 Bn 770.00 Mn 6.36 Bn
8 Mettler Toledo International 28.29 Bn 28.24 Bn 650.22 Mn 3.39 Bn
9 Labcorp Holdings 27.51 Bn 27.37 Bn 1.11 Bn 9.19 Bn
10 Medpace Holdings 17.20 Bn 16.70 Bn 201.64 Mn 1.56 Bn

Historic Data

Download Data
DateValue
Jun 30, 2026 1.56 Bn
Mar 31, 2026 1.47 Bn
Dec 31, 2025 1.46 Bn
Sep 30, 2025 1.40 Bn
Jun 30, 2025 1.35 Bn
Mar 31, 2025 1.25 Bn
Dec 31, 2024 1.23 Bn
Sep 30, 2024 1.17 Bn
Jun 30, 2024 1.13 Bn
Mar 31, 2024 1.10 Bn
Dec 31, 2023 1.07 Bn
Sep 30, 2023 992.69 Mn
Jun 30, 2023 992.93 Mn
Mar 31, 2023 1.03 Bn
Dec 31, 2022 943.41 Mn
Sep 30, 2022 960.98 Mn
Jun 30, 2022 1.01 Bn
Mar 31, 2022 722.11 Mn
Dec 31, 2021 689.26 Mn
Sep 30, 2021 663.00 Mn